division of infectious diseases Archive — Page 1 of 4

Overlapping printed statistical charts, including multicolored bar graphs, line graphs, and a blue-to-red surface plot; some labels and values are visible but too small to read reliably.
December 8, 2023

You missed a few: a better way to count health care-associated influenza cases

The traditional definition of health care-associated influenza leads to gross undercounting, a Vanderbilt study suggests.

Illustration of several teal, curved rod-shaped bacteria with hairlike structures and flagella against a pink-red background.
November 16, 2023

Nasty microbe H. pylori has Achilles’ heel

Vanderbilt researchers found that an H. pylori enzyme is essential for colonization of the stomach, suggesting it as a promising therapeutic target for H. pylori infection.

Professional head-and-shoulders portrait of a bearded man wearing glasses, a white shirt, and striped tie against a neutral brown background.
May 8, 2023

Harris named Department of Medicine’s executive vice chair for Clinical Affairs

Bryan Harris, MD, MPH, MMHC, has been named executive vice chair for Clinical Affairs for Vanderbilt’s Department of Medicine, effective July 1.

Stylized blue human face surrounded by numerous glowing orange, spiked spherical particles against a purple and black background.
April 25, 2023

COVID alters respiratory microbiota

COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions.

VUMC NEWS logo in white lettering inside a cyan and yellow outlined square on a blue gradient background.
March 9, 2023

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.

February 6, 2023

Gut microbiota and lung fibrosis

Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.